Nasdaq

Achieve Life Sciences Reports Positive Results from ORCA-3 Trial of Cytisinicline for Smoking Cessation

Achieve Life Sciences, Inc. announced promising results from its ORCA-3 clinical trial of cytisinicline for smoking cessation, published in JAMA Internal Medicine. This Phase 3 study involved 792 ...
Hosted on MSN

Wave Life Sciences announces positive phase 1 trial results

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
MarketWatch

Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial

The stock of small-cap biotech Wave Life Sciences Inc. soared 51% Tuesday after the company reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne ...
Business Wire

Manifold Raises $18 Million Series B to Define Vertical AI for Life Sciences and Accelerate Life-changing Medicines to Patients

NEWTON, Mass.--(BUSINESS WIRE)--Manifold, the AI platform for life sciences, today announced an $18 million Series B funding round led by Reach Capital, with participation from SilverArc Capital, ...